Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStopping Wegovy is a clinical decision, and the right time depends on your individual health picture rather than hitting a number on the scales. Most adults taking semaglutide for weight management will need to continue long-term to sustain the results; the medicine works while it is active in your body, and weight typically returns after stopping. That said, there are clear situations where stopping is appropriate, and knowing the difference matters. These are prescription-only medicines that require a prescriber's involvement at every stage, including any decision to stop.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
One of the most common misconceptions is that Wegovy 'resets' something in the body permanently, so you can stop once you reach your goal weight. Understandable, but not how the medicine works. Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying while it is present; once you stop, those effects fade, and the appetite signals that drive weight regain reassert themselves.
The evidence is fairly consistent on this. In the STEP 1 trial, published in the New England Journal of Medicine, participants who stopped semaglutide 2.4mg after 68 weeks regained roughly two-thirds of the weight they had lost within a year. That is not a failure of willpower; it reflects biology. Obesity is a chronic condition, and the NHS notes that it often requires long-term management rather than a single course of treatment.
This does not mean everyone must stay on the medicine indefinitely, but it does mean the decision to stop deserves the same clinical attention as the decision to start. If you are wondering when to stop taking Wegovy, the most useful starting point is an honest conversation with your prescriber about your goals, your health status and what the evidence suggests for your situation.
There are clear circumstances where coming off the medicine is the right call, and your prescribing clinician will guide you through each of them.
NICE's recommendation for semaglutide (set out in NICE technology appraisal TA875) includes a specific stopping rule: if you have not lost at least five per cent of your starting body weight after six months on the maintenance dose, continuing is unlikely to be beneficial and should be reviewed. This is built into clinical assessments; it is not a judgement, it is a practical threshold.
Beyond that, there are other reasons a prescriber might advise stopping: a new diagnosis that contraindicates the medicine, a planned surgical procedure (your anaesthetist and surgical team need to know about any GLP-1 medicine before any operation), or if you are planning a pregnancy. Wegovy is not recommended during pregnancy or breastfeeding, and the MHRA advises using contraception throughout treatment. Stopping does not happen immediately before conception, there is a wash-out period your prescriber will set out for you, based on the medicine's half-life.
If you have reached your weight goal and want to explore whether stopping is right for you at this point, that too is a valid reason to have a clinical conversation. Thinking about when you should stop taking Wegovy based on your progress is worth raising at your next review.
Knowing what to expect takes some of the anxiety out of the decision. The weight regain observed in clinical research does not tend to happen overnight. In the STEP 1 extension, most of the regain occurred over roughly twelve months after stopping, with some people regaining more than others depending on lifestyle factors, starting weight and how long they had been on treatment before results became established.
There is more detail on this in our guide on what happens when you stop taking Wegovy, but the short version is: appetite usually increases within a few weeks, food feels less satisfying earlier in the meal, and without changes to diet and activity, weight tends to follow.
The lifestyle habits built during treatment (eating patterns, portion awareness, regular movement) offer some protection. They are not a substitute for the medicine's pharmacological effect, but they do make a difference. Your prescriber or a dietitian is the right person to help you put a plan in place before you stop, rather than after the weight has returned.
If you are already on treatment and curious about whether you can stop taking Wegovy at any point, the clinical position is that it is physically possible to do so, but doing it without a plan and without informing your prescriber is not advisable. A brief look at treatment options is available on our weight-loss treatments overview.
Stopping Wegovy does not require a gradual taper in the way some medicines do; the SmPC does not mandate a formal dose-reduction schedule before stopping. Even so, your prescriber may have views on the timing and context, particularly if you are stopping ahead of surgery or a pregnancy. The right approach is to stop with clinical support rather than just letting your subscription lapse.
A related question that comes up often is whether stopping briefly is an option, say, for a holiday or a period where you cannot store the pens safely. There is more on that in our page on stopping Wegovy for a week, including what to do when you restart. Similarly, if you are thinking about stopping more permanently, our page on how to stop taking Wegovy covers the practical steps.
At nume, every repeat order is reviewed by a GPhC-registered prescriber before it is dispensed. That is precisely the kind of checkpoint where a question about stopping belongs. If you have concerns, raising them there means you get a clinical answer, not a guess. If you are at the point of exploring your options, check your eligibility with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.